BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 28590817)

  • 1. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort.
    Gausman V; Kandel P; Van Riet PA; Moris M; Kayal M; Do C; Poneros JM; Sethi A; Gress FG; Schrope BA; Luk L; Hecht E; Jovani M; Bruno MJ; Cahen DL; Wallace MB; Gonda TA
    Pancreas; 2018 Apr; 47(4):471-476. PubMed ID: 29521942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
    Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
    Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary-mucinous tumor and mucinous cystic neoplasm: CT and MR findings.
    Itai Y; Minami M
    Int J Gastrointest Cancer; 2001; 30(1-2):47-63. PubMed ID: 12489580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management.
    Crippa S; Pezzilli R; Bissolati M; Capurso G; Romano L; Brunori MP; Calculli L; Tamburrino D; Piccioli A; Ruffo G; Fave GD; Falconi M
    Am J Gastroenterol; 2017 Jul; 112(7):1153-1161. PubMed ID: 28244498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of large intraductal papillary mucinous carcinoma of the pancreatic tail.
    Takahashi Y; Sakamoto Y; Shimada K; Sano T; Kosuge T; Onaya H; Mizuguchi Y; Hiraoka N
    Pancreas; 2006 Apr; 32(3):334-5. PubMed ID: 16628093
    [No Abstract]   [Full Text] [Related]  

  • 15. Education and imaging. Hepatobiliary and pancreatic: Non-cystic intraductal papillary mucinous neoplasm of the pancreas.
    Sakamoto K; Hashimoto D; Takamori H; Tokunaga H; Honda Y; Iyama K; Baba H
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1074. PubMed ID: 23782120
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
    Smith LA; McKay CJ
    Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.
    Girometti R; Pravisani R; Intini SG; Isola M; Cereser L; Risaliti A; Zuiani C
    World J Gastroenterol; 2016 Nov; 22(43):9562-9570. PubMed ID: 27920477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
    Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
    J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.
    Pitman MB; Centeno BA; Daglilar ES; Brugge WR; Mino-Kenudson M
    Cancer Cytopathol; 2014 Jan; 122(1):40-7. PubMed ID: 23939829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.